Skip to Content

FDA Approves Oxecta Abuse-Resistant Oxycodone

MONDAY, June 20 -- Oxecta, an abuse-resistant form of the top-selling painkiller oxycodone, has been approved by the U.S. Food and Drug Administration.

Oxecta is similar to Purdue Pharma's best-selling prescription painkiller Oxycontin, a long-acting opioid drug that's commonly abused.

Oxecta shouldn't be used in people who have severe asthma, upper-airway obstruction or chronic obstructive pulmonary disease (COPD), drug makers Pfizer and Acura Pharmaceuticals said in a news release. Common adverse reactions include nausea, constipation, vomiting, headache, itchiness, insomnia, dizziness and lack of energy, the companies said.

Pfizer is based in New York City, and Acura in Palatine, Ill.

More information

The National Library of Medicine has more about oxycodone.

© 2018 HealthDay. All rights reserved.

Posted: June 2011